Bullous pemphigoid treated with Janus kinase inhibitor upadacitinib

• David Nash, BHSc,
• Mark G. Kirchhof, MD, PhD

Affiliations

David Nash, BHSc

Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada

Mark G. Kirchhof, MD, PhD

Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada; Division of Dermatology, Department of Medicine, The Ottawa Hospital, Ottawa, Ontario, Canada; Correspondence to: Mark G. Kirchhof, MD, PhD, Division head, Division of Dermatology, Department of Medicine, University of Ottawa, The Ottawa Hospital Civic Campus, 737 Parkdale Ave, 4th floor, Ottawa, ON K1Y 4M9, Canada.